RP-1664
Phase 1Cancer, Solid tumor/s
Data readoutStock, pipeline and biotech catalyst intelligence
Clinical portfolio
| Asset | Indication | Stage | Milestone | Signals ? |
|---|---|---|---|---|
| RP-1664 | Cancer, Solid tumor/s | Phase 1 | Aug 31, 2026 | — |
Upcoming milestones
Cancer, Solid tumor/s
Data readoutCompany profile
Repare Therapeutics is a biotechnology company in the healthcare sector.
Company profile compiled from available company records. Catalyst dates can change and should be confirmed against the linked primary source.
Page updated Aug 23, 2026 · Yahoo quotes cached for one minute; reference data may be used when a live field is unavailable.